BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 15529184)

  • 1. Analysis of human equilibrative nucleoside transporter 1 (hENT1) protein in non-Hodgkin's lymphoma by immunohistochemistry.
    Chow L; Lai R; Dabbagh L; Belch A; Young JD; Cass CE; Mackey JR
    Mod Pathol; 2005 Apr; 18(4):558-64. PubMed ID: 15529184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of human equilibrative nucleoside transporter 1 (hENT1) protein in the Reed-Sternberg cells of Hodgkin's disease.
    Reiman T; Clarke ML; Dabbagh L; Vsianska M; Coupland RW; Belch AR; Baldwin SA; Young JD; Cass CE; Mackey JR
    Leuk Lymphoma; 2002 Jul; 43(7):1435-40. PubMed ID: 12389626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of human equilibrative nucleoside transporter 1 (hENT1) and its correlation with gemcitabine uptake and cytotoxicity in mantle cell lymphoma.
    Marcé S; Molina-Arcas M; Villamor N; Casado FJ; Campo E; Pastor-Anglada M; Colomer D
    Haematologica; 2006 Jul; 91(7):895-902. PubMed ID: 16818276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.
    Dogan A; Bagdi E; Munson P; Isaacson PG
    Am J Surg Pathol; 2000 Jun; 24(6):846-52. PubMed ID: 10843287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clusterin expression in malignant lymphomas: a survey of 266 cases.
    Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
    Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic role of human equilibrative transporter 1 (hENT1) in patients with resected gastric cancer.
    Santini D; Vincenzi B; Fratto ME; Perrone G; Lai R; Catalano V; Cass C; Ruffini PA; Spoto C; Muretto P; Rizzo S; Muda AO; Mackey JR; Russo A; Tonini G; Graziano F
    J Cell Physiol; 2010 May; 223(2):384-8. PubMed ID: 20082300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FLT3 is implicated in cytarabine transport by human equilibrative nucleoside transporter 1 in pediatric acute leukemia.
    Català A; Pastor-Anglada M; Caviedes-Cárdenas L; Malatesta R; Rives S; Vega-García N; Camós M; Fernández-Calotti P
    Oncotarget; 2016 Aug; 7(31):49786-49799. PubMed ID: 27391351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma.
    Spratlin J; Sangha R; Glubrecht D; Dabbagh L; Young JD; Dumontet C; Cass C; Lai R; Mackey JR
    Clin Cancer Res; 2004 Oct; 10(20):6956-61. PubMed ID: 15501974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic reticulum cell immunoreactivity for low-affinity nerve growth factor receptor in malignant lymphomas.
    Dorfman DM; Shahsafaei A
    Mod Pathol; 1996 Oct; 9(10):959-65. PubMed ID: 8902831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunolocalization of the ICE/Ced-3-family protease, CPP32 (Caspase-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes.
    Krajewski S; Gascoyne RD; Zapata JM; Krajewska M; Kitada S; Chhanabhai M; Horsman D; Berean K; Piro LD; Fugier-Vivier I; Liu YJ; Wang HG; Reed JC
    Blood; 1997 May; 89(10):3817-25. PubMed ID: 9160689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian non-Hodgkin's lymphoma: a clinicopathologic study of eight primary cases.
    Vang R; Medeiros LJ; Warnke RA; Higgins JP; Deavers MT
    Mod Pathol; 2001 Nov; 14(11):1093-9. PubMed ID: 11706069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancer.
    Santini D; Perrone G; Vincenzi B; Lai R; Cass C; Alloni R; Rabitti C; Antinori A; Vecchio F; Morini S; Magistrelli P; Coppola R; Mackey JR; Tonini G
    Ann Oncol; 2008 Apr; 19(4):724-8. PubMed ID: 18187485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia.
    Lai R; Arber DA; Chang KL; Wilson CS; Weiss LM
    Mod Pathol; 1998 Sep; 11(9):864-9. PubMed ID: 9758366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human equilibrative nucleoside transporter 1 is not predictive for gemcitabine efficacy in advanced pancreatic cancer: translational results from the AIO-PK0104 phase III study with the clone SP120 rabbit antibody.
    Ormanns S; Heinemann V; Raponi M; Isaacson J; Laubender RP; Haas M; Kruger S; Kleespies A; Mann E; Bartosiewicz M; Kirchner T; Boeck S
    Eur J Cancer; 2014 Jul; 50(11):1891-9. PubMed ID: 24857044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the nucleoside transporters hENT1 (SLC29) and hCNT1 (SLC28) in pediatric acute myeloid leukemia.
    Jaramillo AC; Hubeek I; Broekhuizen R; Pastor-Anglada M; Kaspers GJL; Jansen G; Cloos J; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(10-12):1379-1388. PubMed ID: 32312148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
    Carbone A; Gloghini A; Gruss HJ; Pinto A
    Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of ZAP-70 in 341 cases of non-Hodgkin and Hodgkin lymphoma.
    Admirand JH; Rassidakis GZ; Abruzzo LV; Valbuena JR; Jones D; Medeiros LJ
    Mod Pathol; 2004 Aug; 17(8):954-61. PubMed ID: 15133473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adhesion molecule expression in CD5-negative/CD10-negative chronic B-cell leukemias: comparison with non-Hodgkin's lymphomas and CD5-positive B-cell chronic lymphocytic leukemia.
    Finn WG; Singleton TP; Schnitzer B; Ross CW; Stoolman LM
    Hum Pathol; 2001 Jan; 32(1):66-73. PubMed ID: 11172297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the expression of human equilibrative nucleotide transporter 1 (hENT1) and ribonucleotide reductase subunit M1 (RRM1) genes in seven non-Hodgkin lymphoma cell lines.
    Zhao HB; Zhang XF; Shi F; Zhang MZ; Xue WL
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.